objectiveacut
pyelonephr
one
frequent
medic
complic
pregnanc
well
common
caus
antepartum
hospit
interferon
ifn
induc
protein
member
cxc
chemokin
famili
proinflammatori
antiangiogen
properti
purpos
studi
determin
whether
matern
serum
concentr
chang
patient
acut
pyelonephr
pregnanc
studi
designthi
crosssect
studi
conduct
determin
differ
matern
serum
concentr
pregnant
women
acut
pyelonephr
normal
pregnant
women
pyelonephr
defin
presenc
posit
urin
cultur
fever
matern
clinic
sign
blood
cultur
perform
case
matern
serum
concentr
measur
sensit
immunoassay
nonparametr
statist
use
analysi
median
serum
concentr
pregnant
patient
pyelonephr
significantli
higher
normal
pregnant
women
median
pgml
rang
vs
median
pgml
respect
p
matern
median
serum
concentr
differ
significantli
among
patient
acut
pyelonephr
without
bacteremia
posit
blood
cultur
median
pgml
rang
vs
neg
blood
cultur
median
pgml
rang
respect
p
conclusionspyelonephr
pregnant
women
associ
increas
matern
serum
concentr
chemokin
acut
pyelonephr
one
frequent
medic
complic
pregnanc
common
caus
antepartum
hospit
case
occur
second
trimest
complic
follow
event
acut
pyelonephr
pregnanc
includ
anemia
transient
renal
dysfunct
preterm
labor
sepsi
septic
shock
moreov
pregnant
women
pyelonephr
increas
risk
develop
acut
respiratori
distress
syndrom
ard
human
interferoninduc
protein
chemokin
cxc
famili
uniqu
featur
member
type
chemokin
proinflammatori
properti
act
modul
angiogenesi
condit
wound
heal
ischemia
neoplasia
dual
properti
relat
share
express
specif
chemokin
receptor
leukocyt
endotheli
cell
induc
proinflammatori
stimuli
tumor
necrosi
virus
microbi
product
either
directli
nfkb
propos
chemokin
also
involv
recruit
potenti
thelper
respons
object
studi
determin
whether
matern
serum
concentr
differ
normal
pregnanc
pregnant
women
acut
pyelonephr
crosssect
studi
includ
normal
pregnant
women
pregnant
patient
acut
pyelonephr
patient
consid
normal
pregnanc
met
follow
criteria
medic
obstetr
surgic
complic
absenc
labor
time
venipunctur
deliveri
normal
term
week
infant
whose
birth
weight
th
th
percentil
gestat
age
acut
pyelonephr
diagnos
presenc
fever
temperatur
clinic
sign
symptom
upper
urinari
infect
eg
flank
pain
costovertebr
angl
tender
pyuria
posit
urin
cultur
blood
cultur
perform
patient
pyelonephr
patient
enrol
detroit
medic
centerhutzel
women
hospit
mi
usa
provid
written
inform
consent
collect
clinic
data
biolog
materi
protocol
approv
institut
review
board
wayn
state
univers
nation
institut
child
health
human
develop
nation
institut
health
nihdhh
mani
sampl
employ
studi
biolog
inflamm
ie
complement
flow
cytometri
hemostasi
angiogenesi
regul
growth
factor
concentr
normal
pregnant
women
complic
sampl
patient
use
studi
biolog
pyelonephr
inflamm
specif
sensit
enzymelink
immunoassay
use
determin
concentr
human
matern
serum
immunoassay
obtain
r
system
minneapoli
mn
usa
briefli
matern
serum
sampl
incub
duplic
well
microtit
plate
precoat
monoclon
antibodi
specif
incub
step
present
standard
matern
serum
bound
immobil
antibodi
repeat
wash
aspir
remov
unbound
substanc
enzymelink
polyclon
antibodi
specif
ad
well
follow
wash
remov
excess
unbound
materi
substrat
solut
ad
well
color
develop
proport
amount
bound
initi
step
color
develop
stop
addit
acid
solut
intens
color
read
use
programm
spectrophotomet
spectramax
molecular
devic
sunnyval
ca
usa
concentr
serum
sampl
determin
interpol
individu
standard
curv
compos
recombin
human
calcul
inter
intra
assay
coeffici
variat
cv
immunoassay
laboratori
lower
limit
detect
sensit
calcul
kolmogorovsmirnov
test
employ
determin
whether
data
normal
distribut
comparison
among
group
perform
use
mannwhitney
test
pvalu
consid
statist
signific
statist
packag
use
spss
v
spss
inc
chicago
il
usa
clinic
obstetr
characterist
women
group
display
tabl
among
patient
acut
pyelonephr
signific
differ
median
serum
concentr
observ
posit
blood
cultur
posit
blood
cultur
median
pgml
rang
vs
neg
blood
cultur
median
pgml
rang
respect
figur
patient
acut
pyelonephr
deliv
neonat
lower
birth
weight
control
group
pyelonephr
median
g
rang
g
vs
normal
pregnanc
median
g
rang
g
howev
mean
gestat
age
deliveri
differ
two
group
princip
find
studi
median
serum
concentr
pregnant
women
acut
pyelonephr
significantli
higher
normal
pregnant
women
among
patient
pyelonephr
signific
differ
median
serum
concentr
observ
posit
blood
cultur
first
report
document
increas
matern
serum
concentr
women
acut
infect
pregnanc
superfamili
chemokin
includ
secret
protein
molecular
weight
kd
select
target
activ
specif
cell
popul
attract
inflam
tissu
microbi
invas
occur
recent
much
discuss
specif
subset
chemokin
particular
leukocyt
popul
eg
neutrophil
lymphocyt
etc
whether
particular
set
chemokin
involv
diseas
process
characterist
type
white
blood
cell
infiltr
recent
find
indic
chemokin
receptor
express
wide
varieti
cell
nonhematopoiet
origin
function
chemokin
extend
far
beyond
white
blood
cell
attract
fundament
observ
ad
complex
field
promiscu
famili
molecul
receptor
inde
chemokin
bind
sever
differ
receptor
chemokin
receptor
bind
one
chemokin
tradit
two
main
subfamili
chemokin
describ
basi
number
arrang
conserv
cystin
residu
cc
cxc
chemokin
cc
chemokin
preferenti
attract
monocyt
basophil
eosinophil
lymphocyt
effect
neutrophil
cxc
chemokin
subdivid
accord
presenc
absenc
glutam
acidleucinearginin
elr
sequenc
elrcontain
cxc
chemokin
elr
chemotact
neutrophil
promot
angiogenesi
contrast
nonelr
contain
cxc
chemokin
elr
chemotact
mainli
lymphocyt
character
antiangiogen
activ
elrcxc
chemokin
first
describ
product
gene
induc
respons
recombin
sever
cell
popul
biolog
properti
mediat
interact
transmembran
g
proteincoupl
receptor
share
two
induc
cxc
chemokin
mig
itac
whose
distinct
biolog
activ
relat
differ
signal
transduct
pathway
gene
protein
express
modul
proinflammatori
stimuli
inde
induc
gene
protein
express
chemokin
mononuclear
cell
neutrophil
eosinophil
keratinocyt
fibroblast
endotheli
cell
pancreat
anim
astrocytesmicroglia
interleukin
well
viral
microbi
product
also
stimul
product
interestingli
vitro
infect
epithelium
urinari
tract
e
coli
result
increas
measur
condit
media
elisa
secret
epitheli
cell
mrna
express
activ
nfkb
pathway
ligat
pattern
recognit
receptor
also
upregul
gene
protein
express
thu
consid
nfkb
respons
gene
proinflammatori
activ
includ
chemotaxi
endotheli
adhes
activ
cell
well
chemotaxi
enhanc
natur
killer
nk
cell
mediat
cytolysi
howev
chemokin
poor
neutrophil
activ
effect
monocyt
b
cell
controversi
topic
infect
associ
increas
serum
andor
plasma
concentr
evid
support
statement
includ
median
serum
concentr
determin
first
postnat
day
significantli
higher
neonat
perinat
infect
control
p
median
serum
concentr
significantli
higher
neonat
nosocomi
infect
compar
control
neonat
plasma
pgml
report
identifi
preterm
infant
sepsi
necrot
enterocol
propos
sever
neonat
infect
associ
magnitud
upregul
circul
inde
plasma
concentr
infant
die
sepsi
markedli
elev
rang
pgml
adult
plasma
concentr
use
monitor
diseas
activ
respons
therapi
mycobacterium
tuberculosi
infect
interestingli
serum
concentr
report
significantli
higher
sever
ard
control
patient
patient
bacteri
pneumonia
chemokin
cytokin
disregul
implic
pathogenesi
ard
propos
use
marker
lung
injuri
patient
sever
acut
respiratori
syndrom
previou
studi
report
higher
serum
urin
concentr
determin
elisa
presenc
cultureproven
gramneg
urosepsi
febril
urinari
tract
infect
control
patient
furthermor
serum
concentr
chang
significantli
followup
h
begin
treatment
howev
signific
decreas
urinari
concentr
observ
serum
urin
concentr
differ
patient
posit
neg
blood
cultur
interest
experiment
endotoxemia
human
concentr
elev
serum
urin
find
increas
concentr
urin
rais
question
chang
peripher
circul
reflect
urin
possibl
reflect
renal
excret
increas
avail
peripher
circul
local
product
first
report
topic
serum
concentr
pregnant
women
pyelonephr
find
pyelonephr
pregnanc
associ
signific
increas
serum
concentr
chemokin
consist
previous
report
nonpregn
patient
mechan
respons
increas
normal
pregnanc
acut
infect
gestat
unknown
addit
physiolog
function
pregnanc
well
role
acut
infect
gestat
remain
determin
recent
demonstr
antimicrobi
properti
thu
tempt
postul
chemokin
particip
host
defens
orchestr
leukocyt
chemotaxi
also
induc
biolog
activ
may
protect
effect
infect
studi
signific
differ
observ
median
matern
serum
concentr
patient
without
posit
blood
cultur
otto
et
al
report
similar
result
quantifi
urinari
respons
febril
urinari
tract
infect
inde
chemokin
significantli
higher
presenc
bacteremia
one
interpret
elev
serum
concentr
context
pyelonephr
result
system
inflamm
affect
presenc
microorgan
circul
howev
one
possibl
explan
neg
result
limit
statist
power
migrat
immunocompet
cell
site
mucos
infect
requir
express
molecul
epitheli
cell
affect
tissu
chemokin
particularli
belong
cxc
famili
shown
play
import
role
process
inde
infect
mucosa
associ
local
increas
evid
support
statement
includ
exposur
uroepitheli
cell
e
coli
follow
signific
increas
mrna
express
quantif
rna
protect
assay
protein
secret
elisa
intraves
instil
mycobacterium
bovi
bacillu
calmetteguerin
bcg
follow
detect
urinari
patient
undergo
immunotherapi
bladder
cancer
elisa
condit
media
collect
cultur
human
uroepitheli
cell
line
expos
bcg
bcgderiv
cytokin
contain
significantli
higher
amount
elisa
control
media
intrapulmonari
administr
pneumonia
mice
follow
upregul
mrna
express
lung
moreov
neutral
activ
antibodi
result
reduc
bacteri
clearanc
decreas
surviv
contrast
overexpress
via
adenoviru
result
improv
bacteri
clearanc
recent
studi
report
structur
similar
chemokin
defensin
famili
antimicrobi
peptid
serv
first
line
defens
epithelia
activ
adapt
immun
follow
evid
suggest
overlap
biolog
function
defensin
chemokin
share
mani
properti
defensin
structur
size
charg
disulfid
bond
ifninduc
cxc
motif
present
contain
conserv
defensin
well
structur
relat
shown
chemotact
leukocyt
subnanomolar
concentr
antimicrobi
properti
similar
defensin
radial
diffus
assay
demonstr
antimicrobi
activ
e
coli
listeria
monocytogen
moreov
antimicrobi
activ
similarli
activ
defensin
mani
antimicrobi
peptid
salt
depend
inhibit
nacl
calcul
amount
produc
infiltr
inflammatori
cell
indic
tissu
concentr
chemokin
may
reach
threshold
necessari
microbicid
activ
local
directli
inactiv
microb
attract
host
defens
cell
area
compar
nonpregn
subject
pyelonephr
mother
pyeloneprhti
increas
risk
ard
attribut
enhanc
baselin
activ
innat
immunorespons
pregnanc
although
explan
may
possibl
inde
excess
inflammatori
respons
particular
neutrophil
activ
implic
pathogenesi
ard
nevertheless
precis
mechan
associ
pyelonephr
ard
remain
determin
neumann
et
al
caus
lung
injuri
femal
mice
induc
continu
leakag
bacteria
periton
caviti
investig
demonstr
procedur
caus
earli
three
hour
massiv
recruit
granulocyt
lung
signific
increas
lung
mrna
author
conclud
may
contribut
accumul
mononuclear
phagocyt
lung
thu
may
involv
pathogenesi
ard
pregnant
women
sepsi
andor
pyelonephr
hypothesi
strengthen
observ
patient
sar
serum
concentr
increas
develop
chest
involv
reach
peak
concentr
abnorm
detect
chest
xray
matern
serum
concentr
higher
context
acut
bacteri
infect
pyelonephr
normal
pregnanc
role
chemokin
host
defens
infect
requir
studi
matern
serum
concentr
patient
pyelonephr
signific
differ
matern
median
serum
concentr
observ
patient
posit
neg
blood
cultur
median
pgml
rang
vs
median
pgml
rang
respect
